MTA Family of Coregulators in Nuclear Receptor Biology and Pathology

Overview

Journal Nucl Recept Signal

Publisher Sage Publications

Specialty Biochemistry

Date 2008 Jan 5

PMID 18174918

Citations 54

Authors

Bramanandam Manavathi

Kamini Singh

Rakesh Kumar

Affiliations

Soon will be listed here.

Abstract

Nuclear receptors (NRs) rely on coregulators (coactivators and corepressors) to modulate the transcription of target genes. By interacting with nucleosome remodeling complexes, NR coactivators potentiate transcription, whereas corepressors inhibit transcription of the target genes. Metastasis-associated proteins (MTA) represent an emerging family of novel NR coregulators. In general, MTA family members form independent nucleosome remodeling and deacetylation (NuRD) complexes and repress the transcription of different genes by recruiting histone deacetylases onto their target genes. However, MTA1 also acts as a coactivator in a promoter-context dependent manner. Recent findings that repression of estrogen receptor transactivation functions by MTA1, MTA1s, and MTA2 and regulation of MTA3 by estrogen signaling have indicated the significance of these proteins in NR signaling. Here, we highlight the action of MTA proteins on NR signaling and their roles in pathophysiological conditions.

Citing Articles

Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling.

Yang L, Steen T, Espinoza I, Cuyas E, Verdura S, Menendez J Am J Cancer Res. 2022; 12(5):2173-2188.

PMID: 35693067 PMC: 9185626.

NuRD subunit MTA1 interacts with the DNA non-homologous end joining Ku complex in cancer cells.

Liu J, Liu Q, Wang H, Li C, Wen T, An G RSC Adv. 2022; 8(61):35218-35225.

PMID: 35547075 PMC: 9087872. DOI: 10.1039/c8ra06907g.

The effect of progesterone administration on the expression of metastasis tumor antigens (MTA1 and MTA3) in placentas of normal and dexamethasone-treated rats.

Alawadhi M, Al Shammari F, Ali F, Almatar R, Al-Duwaikhi A, Al-Bader M Mol Biol Rep. 2022; 49(3):1935-1943.

PMID: 35037193 DOI: 10.1007/s11033-021-07005-5.

MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis.

Lin C, Ying T, Yang S, Chiou H, Chen Y, Kao S Cell Death Dis. 2021; 12(5):451.

PMID: 33958583 PMC: 8102478. DOI: 10.1038/s41419-021-03729-1.

Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy.

Levenson A Semin Cancer Biol. 2020; 80:107-117.

PMID: 32126261 PMC: 7483334. DOI: 10.1016/j.semcancer.2020.02.012.

References

von Zelewsky T, Palladino F, Brunschwig K, Tobler H, Hajnal A, Muller F . The C. elegans Mi-2 chromatin-remodelling proteins function in vulval cell fate determination. Development. 2000; 127(24):5277-84. DOI: 10.1242/dev.127.24.5277. View

Balasenthil S, Gururaj A, Talukder A, Bagheri-Yarmand R, Arrington T, Haas B . Identification of Pax5 as a target of MTA1 in B-cell lymphomas. Cancer Res. 2007; 67(15):7132-8. DOI: 10.1158/0008-5472.CAN-07-0750. View

Mazumdar A, Wang R, Mishra S, Adam L, Mandal M, Vadlamudi R . Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol. 2001; 3(1):30-7. DOI: 10.1038/35050532. View

Xia L, Zhang Y . Sp1 and ETS family transcription factors regulate the mouse Mta2 gene expression. Gene. 2001; 268(1-2):77-85. DOI: 10.1016/s0378-1119(01)00429-2. View

Sasaki H, Yukiue H, Kobayashi Y, Nakashima Y, Kaji M, Fukai I . Expression of the MTA1 mRNA in thymoma patients. Cancer Lett. 2001; 174(2):159-63. DOI: 10.1016/s0304-3835(01)00704-2. View

Chen Z, Han M . Role of C. elegans lin-40 MTA in vulval fate specification and morphogenesis. Development. 2001; 128(23):4911-21. DOI: 10.1242/dev.128.23.4911. View

Sasaki H, Moriyama S, Nakashima Y, Kobayashi Y, Yukiue H, Kaji M . Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer. 2002; 35(2):149-54. DOI: 10.1016/s0169-5002(01)00329-4. View

McKenna N, OMalley B . Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 2002; 108(4):465-74. DOI: 10.1016/s0092-8674(02)00641-4. View

Kumar R, Wang R, Mazumdar A, Talukder A, Mandal M, Yang Z . A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature. 2002; 418(6898):654-7. DOI: 10.1038/nature00889. View

10.

Brackertz M, Boeke J, Zhang R, Renkawitz R . Two highly related p66 proteins comprise a new family of potent transcriptional repressors interacting with MBD2 and MBD3. J Biol Chem. 2002; 277(43):40958-66. DOI: 10.1074/jbc.M207467200. View

11.

Talukder A, Mishra S, Mandal M, Balasenthil S, Mehta S, Sahin A . MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. J Biol Chem. 2003; 278(13):11676-85. DOI: 10.1074/jbc.M209570200. View

12.

Hamatsu T, Rikimaru T, Yamashita Y, Aishima S, Tanaka S, Shirabe K . The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep. 2003; 10(3):599-604. View

13.

Fujita N, Jaye D, Kajita M, Geigerman C, Moreno C, Wade P . MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell. 2003; 113(2):207-19. DOI: 10.1016/s0092-8674(03)00234-4. View

14.

Mishra S, Mazumdar A, Vadlamudi R, Li F, Wang R, Yu W . MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J Biol Chem. 2003; 278(21):19209-19. DOI: 10.1074/jbc.M301968200. View

15.

Grune T, Brzeski J, Eberharter A, Clapier C, Corona D, Becker P . Crystal structure and functional analysis of a nucleosome recognition module of the remodeling factor ISWI. Mol Cell. 2003; 12(2):449-60. DOI: 10.1016/s1097-2765(03)00273-9. View

16.

Yao Y, Yang W . The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem. 2003; 278(43):42560-8. DOI: 10.1074/jbc.M302955200. View

17.

Hofer M, Kuefer R, Varambally S, Li H, Ma J, Shapiro G . The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res. 2004; 64(3):825-9. DOI: 10.1158/0008-5472.can-03-2755. View

18.

Bowen N, Fujita N, Kajita M, Wade P . Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta. 2004; 1677(1-3):52-7. DOI: 10.1016/j.bbaexp.2003.10.010. View

19.

Toh Y, Ohga T, Endo K, Adachi E, Kusumoto H, Haraguchi M . Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer. 2004; 110(3):362-7. DOI: 10.1002/ijc.20154. View

20.

Moon W, Chang K, Tarnawski A . Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Hum Pathol. 2004; 35(4):424-9. DOI: 10.1016/j.humpath.2003.11.007. View